Skip to main content
Caplight Logo









AURIMOD GmbH

AURIMOD GmbH

Private
ViennaHealthcare & Life Scienceshttps://aurimod.com/

Last Round

Grant

Oct 1, 2019

Total Funding Raised

$2.43M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

AURIMOD GmbH is a medical technology company that develops wearable neuromodulation devices for the personalized, non-pharmacological treatment of chronic pain.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Health IoT, Patient Engagement

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Application

Keywords

neuromodulationauricular vagus nerve stimulationaVNSvagus nerve stimulatormedical wearablepain managementchronic pain treatmentmedtechdigital healthnon-pharmacological pain reliefpain diarybioelectronic medicinedigital biomarkertherapy optimizationwearable tech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

AURIMOD GmbH Comparables

Compare AURIMOD GmbH with similar companies based on industry and business-model similarity.

AURIMOD GmbH comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Soterix Medical
79%
Parasym
79%
JBA Health
76%

AURIMOD GmbH Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantOct 1, 2019

Key People

Founding team and executive leadership

Stefan Kampusch

Chief Executive Officer

Executive Team

Bernhard Fabian

Chief Operating Officer, Head of QM & RA, PRRC

Executive Team

AURIMOD GmbH Investors

Notable investors and investment history

AURIMOD GmbH investors
InvestorRounds
ILUM TecEarly Funding
European UnionGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 24, 2026

    Monthly visitors grew 439% MoM, from 241 to 1.3K.

  • Nov 16, 2025

    Grew 31% QoQ, from 13 to 17 employees.

AURIMOD GmbH Filings

Explore SEC and related filing metadata, where available.

AURIMOD GmbH filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about AURIMOD GmbH's valuation, stock price, and market status.

Is AURIMOD GmbH a public or private company?

AURIMOD GmbH is a private company.

What is the current stock price of AURIMOD GmbH?

AURIMOD GmbH is a private company with no public stock price. No recent secondary market data is available.

How much is AURIMOD GmbH worth (valuation)?

Valuation information for AURIMOD GmbH is not publicly available.

Can I buy AURIMOD GmbH stock?

AURIMOD GmbH shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was AURIMOD GmbH's last funding round?

AURIMOD GmbH's most recent funding round was Grant on October 1, 2019.

Who are the main investors in AURIMOD GmbH?

Key investors in AURIMOD GmbH include ILUM Tec, European Union.

Will AURIMOD GmbH IPO soon?

No public IPO plans have been announced for AURIMOD GmbH.

How can I track AURIMOD GmbH secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor AURIMOD GmbH's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersVienna
Employee Range13
Year Founded2015
Last FundingOct 1, 2019

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?